Vimarsana
Biggest News Aggregation in the World

Page 3 - Ject Systems News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ject Systems. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ject Systems Today - Breaking & Trending Today

Fareva and ApiJect sign a licensing agreement to create a France-based 500M unit annual capacity for single-dose prefilled vaccine injections - Vimarsana News

Fareva and ApiJect sign a licensing agreement to create a France-based 500M unit annual capacity for single-dose prefilled vaccine injections

/PRNewswire/ -- Fareva and ApiJect Systems, Corp. today announced a 10-year licensing agreement to install three Blow-Fill-Seal production lines that when...

Fareva And ApiJect Sign A Licensing Agreement To Create A France-Based 500M Unit Annual Capacity For Single-Dose Prefilled Vaccine Injections - Vimarsana News

Fareva And ApiJect Sign A Licensing Agreement To Create A France-Based 500M Unit Annual Capacity For Single-Dose Prefilled Vaccine Injections

Fareva and ApiJect Systems, Corp. announced a 10-year licensing agreement to install three Blow-Fill-Seal production lines that when operational will...

Shining Much-Needed Light on the Defense Production Act - Vimarsana News

Shining Much-Needed Light on the Defense Production Act

Shining Much‐​Needed Light on the Defense Production Act SHARE Ever since the pandemic began, the little‐​known, cold war‐​era Defense Production Act has played a prominent role in the U.S. government’s response to COVID-19. At the vigorous urging of a bipartisan swath of politicians and commentators, both Presidents Trump and Biden repeatedly invoked the DPA, which confers upon the executive branch broad powers to compel (Title I) or subsidize (Title III) private actors in the United States on “national security” grounds, in order to expand the domestic production a...

Source: cato.org
The US Awarded a Firm $1.3 Billion to Make Syringes. Where Are They? - Vimarsana News

The US Awarded a Firm $1.3 Billion to Make Syringes. Where Are They?

The US Awarded a Firm $1.3 Billion to Make Syringes. Where Are They? The COVID vaccines are here, but the ApiJect syringe is not yet approved by federal regulators and a new factory in North Carolina is not yet built Published 3 hours ago ApiJect Systems America via AP A year after a Connecticut company was awarded almost $1.3 billion in federal loans and contracts to supply an essential syringe for the COVID-19 vaccine rollout, no syringes have been made. The syringe hasn't received even the first of a series of approvals it needs from the federal government before it can be manufa...

Source: necn.com
citybizlist : New York : ApiJect Systems, Corp., Announces Company's New Leadership Advisory Board - Vimarsana News

citybizlist : New York : ApiJect Systems, Corp., Announces Company's New Leadership Advisory Board

1/28/21 Heidi J. Larson, Ph.D., ApiJect Systems, Corp, a public benefit corporation based in Stamford, CT., announced today the creation of its new Leadership Advisory Board, along with the appointment of the Board's initial six outside members. They will join ApiJect's co-founder and Chairman, Jay Walker, and company CEO, Franco Negron, on this new Board. Mr. Walker and Mr. Negron will serve as ex-officio board members. ApiJect Systems, Corp., is a global injectable technology company. The company is building the world's largest pharmaceutical fill and finish manufacturing facilities in Durh...